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Ethnopharmacological relevance: The role of Azadirachta indica (neem) against Chagas disease and its
antibiotic and antidiabetic action have been demonstrated in non-pregnant animals. However, the
effects of neem on lipid metabolism and oxidative stress during pregnancy remain to be investigated.
The objective of this study was to evaluate the effects of Azadirachta indica (neem) on maternal
reproductive performance and biochemical parameters in non-diabetic and streptozotocin-induced
mild diabetic rats (MD).
Materials and methods: Pregnant rats were randomly distributed into six experimental groups:
ND¼non-treated non-diabetic (n¼13); NDOil¼non-diabetic treated with 1.2 mL/day neem seed oil
(n¼12); NDPA¼non-diabetic treated with 1.0 mg/mL/day azadirachtin (n¼12); D¼non-treated
diabetic (n¼13); DOil: diabetic treated with neem seed oil (n¼12), and DPA¼diabetic treated with
azadirachtin, n¼13. Treatment with either neem oil (1.2 mL/day) or azadirachtin (1.0 mg/mL/day) was
orally administered throughout pregnancy. Glucose test tolerance (GTT) was performed at day 17 of
pregnancy and used as an inclusion criterion. At term pregnancy, maternal reproductive outcomes, lipid
proﬁle and oxidative stress status were assessed.
Results: Treatment with neem oil and azadirachtin during pregnancy (1) had no hypoglycemic and
anti-hyperglycemic effects on non-diabetic and diabetic rats, respectively; (2) affected OGTT glycemic
levels in diabetic rats; (3) increased the proportion of fetuses classiﬁed as small for pregnancy age (SPA)
in all groups; and (4) did not interfere with the lipid proﬁle in non-diabetic dams. Neem oil reduced the
rate of total cholesterol and NEFA in diabetic animals. Both neem oil and azadirachtin increased
lipoperoxidation, characterized by increased MDA levels in non-diabetic rats.
Conclusion: Both neem seed oil and azadirachtin impaired intrauterine development and altered
antioxidant/oxidative status during pregnancy.
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Diabetes mellitus (DM) is a group of heterogeneous metabolic
disorders characterized by hyperglycemia resulting from defec-
tive insulin secretion, resistance to insulin action or both
(Hamada et al., 2009). Experimental and clinical studies have
demonstrated that diabetes during pregnancy increases the
risk of reproductive anomalies, intrauterine death, prematurity,
perinatal mortality and congenital malformations.
Pregnancy per se is a state of oxidative stress (Myatt and Cui,
2004) arising from maternal hyperlipidemia and reduced scaven-
ging power of antioxidants (de Souza et al., 2010). Besides,
enhanced production of reactive oxygen species (ROS) has been
found in diabetics, where oxygen free radicals are thought to be
produced as a result of prolonged periods of exposure to
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rats, signiﬁcant increases in concentration of thiobarbituric acid
reactive substances (TBARSs) and activities of superoxide dismu-
tase (SOD) and glutathione peroxidase (GSH-Px) (Rudge et al.,
2007) have been reported.
Several herbal components (Damasceno and Volpato, 2008)
and drugs (Cooppan, 2005; Davidson, 2001) have been used in an
attempt to control diabetes and attenuate its complications
during pregnancy in both women and experimental animals.
Azadirachta indica A. Juss (Meliaceae), commonly called neem, is
a tree native to India and Bhurma renowned for its medicinal
properties. In (1986), Dixit et al. demonstrated the anti-
hyperglycemic and hypoglycemic activities of neem seed oil in
alloxan-induced diabetic female rats. Despite being frequently
used, even by pregnant women, as an antidiabetic agent, the
effects of Azadirachta indica against Chagas disease (Mbaya et al.,
2010) as well as its antibiotic (Sharma et al., 2009) and antidia-
betic (Waheed et al., 2006; Bhat et al., 2011) actions have only
been demonstrated in non-pregnant animals. To our knowledge,
the effects of neem on lipid metabolism and oxidative stress
during pregnancy remain uninvestigated.
Given that the repercussions of severe diabetes on fetal
development are well established, several studies have been
performed in our laboratory to evaluate maternal, placental and
fetal outcomes in pregnant rats with mild hyperglycemia (glyce-
mia between 120 and 300 mg/dL) induced by streptozotocin at
birth. Our results showed that mild hyperglycemia leads to
intrauterine growth restriction, major birth defects (Saito et al.,
2010), and decreased maternal reproductive performance
(Damasceno et al., 2011). Additionally, maternal IL-10 was found
to be predictive of fetal abnormalities (Sinzato et al., 2011) and
maternal metabolic disturbances, such as hyperlipidemia and
enhanced oxidative stress (Wisdom et al., 1991).
The objective of the present study was to assess the effects of
Azadirachta indica (neem) on lipid proﬁle, oxidative stress status
and glycemic status in both non-diabetic and mildly diabetic
pregnant rats.2. Materials and methods
2.1. Extraction of plant materials
We obtained neem oil and alcohol extract containing the
active principle (azadirachtin) from commercially available
washed seeds of Azadirachta indica purchased from Base Fertil
Ltda. (Ribeir~ao Preto, Brazil). According to the company, the oil
was obtained by ﬁrst pressing of the seeds at room temperature
followed by ﬁltration with a Whatmans ﬁlter paper and the
azadirachtin was obtained by micronization of the seeds followed
by solvent extraction using ethanol 70% (v/v) and the amount of
azadirachtin was quantiﬁed by liquid chromatography (HPLC).
Seed samples were authenticated as those of Azadirachta indica A.
Juss by the Mogiense Herbarium, University of Mogi das Cruzes,
S~ao Paulo, Brazil.2.2. Experimental animals
This study was conducted in accordance with the Guide for
Care and Use of Laboratory Animals, and was approved by the
local Committee of Ethics in Animal Experimentation. Female and
male Sprague Dawley (SD) rats weighing approximately 190 g and
220 g, respectively, were provided by CEMIB—Campinas State
University (UNICAMP). The animals were kept under standard
laboratory conditions (2273 1C, 12-h light/dark cycle), fed withrat pellets (Purina rat chow, Purinas, S~ao Paulo State, Brazil) and
tap water ad libitum.
An experimental pilot study was conducted to choose the best
dose. We initially tested concentrations 2.4 and 4 mL/day. How-
ever, they had toxic/lethal effects. Thus we reduced the concen-
tration to 1.2 mL/day twice a day to reproduce human conditions
and maintain the plant effect in the animal body. The same
occurred when azadirachtin doses were tested. The initial con-
centrations of 2.0 and 3.0 mg/mL/day had to be reduced to
1.0 mg/mL/day.
Non-diabetic female rats were mated with non-diabetic males.
At birth (day 0), their female offspring were subcutaneously
injected with 100 mg/kg streptozotocin (STZ—Sigma Chemical
Company, St. Louis, Millstone, USA) dissolved in citrate buffer
(0.1 M, pH 4.5) (Portha et al., 1974; Tsuji et al., 1988). The control
group received only subcutaneous citrate buffer. All pups
remained with their mothers until they reached adulthood
(day 21). All adult females (non-diabetic and diabetic) were
mated overnight with non-diabetic males. The morning when
sperm was found in the vaginal smear was designated as day 0 of
pregnancy. The mating protocol was followed for 15 consecutive
days, i.e. approximately three estrous cycles. The females that
failed to become pregnant during this period were considered
infertile and excluded from the study (de Souza et al., 2010).
2.3. Experimental groups
Pregnant rats were randomly distributed into six experimental
groups: ND¼non-treated non-diabetic (n¼13); NDOil¼non-dia-
betic treated with 1.2 mL/day neem seed oil (n¼12); NDPA¼non-
diabetic treated with 1.0 mg/mL/day azadirachtin (n¼12);
D¼non-treated diabetic (n¼13); DOil¼diabetic treated with
neem seed oil (n¼12); DPA¼diabetic treated with azadirachtin,
n¼13. Treatment was administered by gavage twice a day
throughout pregnancy. Oil treatment consisted of 0.6 mL oil in
the morning and 0.6 mL in the afternoon. Azadirachtin reconsti-
tuted in 1 mL distilled water was also given, in the morning
(0.5 mg/mL) and in the afternoon (0.5 mg/mL).
2.4. Course of pregnancy
At days 0, 7, 14 and 20 of pregnancy, we collected blood
samples from the tail tip, assessed glucose levels by a One-Touch
Ultra Johnson & Johnsons glucometer, and estimated the glyce-
mic mean by averaging the glucose measurements taken. At day
17, the oral glucose tolerance test (OGTT) was performed to
conﬁrm the diabetic status of the animals during pregnancy. After
a six-hour fasting period, glucose dissolved in distilled water was
administered by gavage (2 g/kg body weight) and blood samples
were obtained from the tail tip for glucose measurement at 0, 10,
20, 30 and 120 min (Mello et al., 2001). The non-diabetic rats
presenting glycemia o140 mg/dL, and the rats treated with STZ
at birth showing glycemia 4140 mg/dL at more than two OGTT
time points remained in the group to which they were initially
assigned while those with other abnormalities were excluded.
At day 21 of pregnancy, all rats were anesthetized with 80 mg/kg
sodium thiopental (Thiopentaxs Crista´lia Produtos Quı´micos e
Farmaceˆuticos Ltda., S~ao Paulo, Brasil) and humanely killed.
Maternal blood was then collected from the inferior vena cava
and placed into two tubes—one with anticoagulant for obtaining
erythrocytes and another without anticoagulant for serum
separation. The uterus was removed and weighed, and the ovaries
and uterine contents examined to determine the number of
corpora lutea, implantation sites and embryonic death rate
(number of resorptions), fetal weight and number of live fetuses.
Uteri without visible implantation sites were stained with 10%
Table 1
Fatty acid proﬁle of neem oil compared to olive oil.
FA Neem oil Olive oil
Mean SE Mean SE
16:0 15.92 0.12 11.50 0.08
18:0 16.68 0.03 3.37 0.01
18:1 (x-9) 42.68 0.26 77.02 0.03
18:2 (x-6) 21.41 0.07 5.89 0.06
18:3 (x-3) 0.72 0.00 0.63 0.00
20:0 1.40 0.00 0.36 0.01
20:1 (x-9) 0.08 0.01 0.22 0.00
22:5 (x-6) 0.08 0.01 0.07 0.02
24:0 0.24 0.00 n.d. n.d.
Values are expressed as mean7standard error of mean (SEM).
Fig. 1. Gestational glycemic mean in the groups non-treated non-diabetic (ND, n¼13),
neem oil-treated non-diabetic (NDOil¼12), azadirachtin-treated non-diabetic
(NDPA¼12), non-treated diabetic (D¼13), neem oil-treated diabetic (DOil¼12), and
azadirachtin-treated diabetic (DPA¼13). *po0.05—Signiﬁcantly different from the
non-diabetic group (Test of Multiple Comparison of Tukey).
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calculated as total number of live fetuses/total number of
implantations. All viable fetuses were weighed and classiﬁed as
small for pregnancy age (SPA) when weightothan mean control
weight 1.7 SD; appropriate for pregnancy age (APA) when
weight ¼ mean control weight 71.7 SD; and large for preg-
nancy age (LPA) when weight4mean control weight þ1.7 SD.
The proportion of cases in each category was expressed as
percentage (Merzouk et al., 2000).
2.5. Analytical methods
The fatty acid proﬁle of neem oil was determined in compar-
ison with olive oil. Lipids were extracted from 0.20 ml of neem oil
into chloroform/methanol (2:1) (Folch et al., 1957). Fatty acids
were transesteriﬁed with acetyl chloride while fatty acid methyl
esters were separated and analyzed on a Perkin–Elmer gas
chromatograph (Autosystem; Norwalk, CT, USA), as reported
elsewhere (Amusquivar et al., 2011).
Blood samples collected without anticoagulant were main-
tained in ice for 30 min and then centrifuged at 263g for 10 min at
4 1C. The supernatant was collected and stored at 80 1C for the
later analysis of total cholesterol (CHO), triglycerides (TG) and
high-density lipoprotein (HDL) using the Wieners assay kit
(Rosario, Argentina). Non-esteriﬁed fatty acids (NEFA) were
assessed according to Moura et al. (2002).
Blood collected in tubes with anticoagulant was centrifuged at
90g for 10 min at 4 1C. The supernatant was discarded and
erythrocytes were washed with phosphate buffer saline (0.01 M,
pH 7.4) followed by centrifugation at 263g for 1 min at 4 1C. This
procedure was repeated three times and ﬁnal infranatants were
used for the evaluation of superoxide dismutase activity (SOD),
thiol groups (SH) and glutathione peroxidase activity (GSH-Px),
and malonaldehyde (MDA) as described by de Souza et al. (2010).
2.6. Statistics
The minimum sample size was estimated to be 12 animals per
group. Results are expressed as mean7standard deviation. We
used the test of Multiple Comparison of Tukey for the analysis of
glycemic mean, fetal viability, fetal weight, malonaldehyde and
cholesterol level. The Chi-square test was used to classify fetal
weight. When data were not normally distributed, the tests of log
Binomial Distribution (for non-esteriﬁed fatty acid concentration),
Fisher’s Exact Test (reabsorption), Poisson Distribution (for implan-
tation and live fetus numbers), and Normal Gamma Distribution
(for OGTT and AUC) were used. Analyses were performed using
SAS (Statistical Analysis System) version 9.2 software. Statistical
signiﬁcance was set at po0.05.3. Results
In comparison with olive oil, neem oil showed a higher
proportion of saturated fatty acids (palmitic 16:0 and stearic acid
18:0), lower proportion of oleic acid (18:1, o-9) and higher
proportion of linoleic acid (18:2, o-6). Minor differences were
seen regarding other polyunsaturated fatty acids of smaller
proportions (Table 1).
Of 54 female rats that received citrate buffer, 81% mated. Of
the 122 females that received streptozotocin (STZ) at birth, 38%
mated when adults (data not shown).
Gestational glycemic mean was higher in diabetic than in non-
diabetic rats (po0.05), and remained unchanged after treatment
with oil or azadirachtin in both non-diabetic and diabetic animals
(p40.05) as compared to their respective controls (Fig. 1).Fig. 2 shows the OGTT curves at day 17 of pregnancy in all
experimental groups. No signiﬁcant difference was found among
groups ND, NDOil and NDPA (Fig. 2A). In the DOil group, glycemia
values were lower (po0.05) at 10 and 20 min, and higher at
30 and 120 min than in group D (Fig. 2B). In the DPA group,
glycemic values at 30 and 120 min were higher (po0.05) than in
group D (Fig. 2B).
No signiﬁcant difference was observed in the number of
corpora lutea among experimental groups. D rats showed
decrease (po0.05) in number of implantations, number of live
fetuses and fetal viability rate and increase in resorption rate
compared to group ND. In the NDA group, the number of live
fetuses was decreased (po0.05) and resorption rate was
increased (po0.05) in comparison with group ND. The NDOil
group showed a higher (po0.05) resorption rate than group ND.
In the groups DOil and DPA, weight gain was lower than in group
D (po0.05) (Table 2). In groups D (compared to ND), DOil and
DPA (compared to D) the proportion of fetuses classiﬁed as small
for pregnancy age (SPA) was signiﬁcantly increased (Fig. 3).
Table 3 shows that antioxidant enzymes superoxide dismutase
(SOD) and glutathione peroxidase (GSH-Px) activity as well as
thiol groups concentration (SH) did not differ among groups
(p40.05). Malonaldehyde (MDA) concentration was increased
in NDOil, NDPA and D (po0.05) in comparison with group ND. In
groups DOil and DPA, MDA did not differ from group D (p40.05).
The concentrations of total cholesterol, triglycerides, HDL-c
and non-esteriﬁed fatty acids (NEFA) in NDOil and NDPA were not
statistically different (p40.05) compared to those of group ND.
Non-esteriﬁed fatty acid rate was increased (po0.05) in D rats in
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(po0.05) levels of total cholesterol and NEFA compared with
those in group D (Table 4).4. Discussion
In this study, treatment with neem oil and azadirachtin had no
hypoglycemic and anti-hyperglycemic effects on non-diabetic and
diabetic rats, respectively. Literature reports on neem hypogly-
cemic and anti-hyperglycemic activity are conﬂicting. In a clinical
study, neem aqueous extract and alcoholic extract at high doses
had a hypoglycemic effect on patients with type 2 diabetes
(Waheed et al., 2006). Experimentally, different parts of the plant
differently prepared and different administration routes have
been tested. Radwan et al. (2001) demonstrated that sub-acuteTable 2
Maternal reproductive performance in all groups at term pregnancy.
ND (n¼13) NDOil (n¼12) N
Number of corpora lutea 14.3672.44 14.5072.39 14
Number of implantationsa 13.2672.82 13.7572.77 11
Number of live fetusesa 12.8272.91 12.5873.23 10
Resorption (%)b 33 50n 45
Fetal viability ratio (%)c 96 92 92
Fetal weight (g)c 5.4170.43 5.1770.53 5.
Values are expressed as mean7standard deviation (SD).
n Signiﬁcant difference as compared to ND.
# Signiﬁcant difference as compared to D.
a po0.05—Poisson distribution.
b po0.05—Fisher’s exact test.
c po0.05—Test of Multiple Comparison of Tukey.
Fig. 2. Oral glucose tolerance test at day 17 of pregnancy in non-diabetic (A) and
diabetic (B) groups. po0.05—Normal Gamma Distribution: #Signiﬁcant difference
between DOil and D; $Signiﬁcant difference between DPA and D.exposure to azadirachtin increased glycemia in normoglycemic
rats. On the other hand, a hypoglycemic effect was observed in
diabetic rabbits treated with neem seed oil and azadirachtin
(Khosla et al., 2000), in rats treated with neem oil alone (Dixit
et al., 1986), and in rats treated with intraperitoneal neem
methanolic extract (Bhat et al., 2009). These ﬁndings suggest that
the part of the plant and the extraction technique used signiﬁ-
cantly inﬂuence the results obtained.
In this study, basal insulin concentration remained unchanged
(data not shown) and OGTT levels increased in diabetic rats treated
with neem oil and azadirachtin. These observations disagree with
Chandra et al. (2008), who suggested that natural products may exert
their membrane-stabilizing effects on the pancreas to regulate insulin
biosynthesis and secretion in order to act as the hypoglycemic agent
in diabetic rats. However, they are in line with Bhat et al. (2009) who
reported improved glucose tolerance status in diabetic mice treated
with neem methanol and chloroform extracts.
In non-treated diabetic rats, we observed a decreased number
of implantations and increased resorption rates (embryonic
deaths) that corroborate literature pointing out that uncontrolled
diabetes during pregnancy elevates the rates of intra-uterine
death and abortion in both women (Eriksson et al., 2003; Yang
et al., 2006) and laboratory animals (Saito et al., 2010). Maternal
hyperglycemia affects the viability of early embryos and/or alter
maternal decidua, impairing embryonic implantation (Fraser
et al., 2007). Moreover, Reece et al. (2004) observed that diabetic
dams without treatment presented a reduced number of viable
fetuses and, consequently an increased loss rate after embryonicDPA (n¼12) D (n¼13) DOil (n¼12) DPA (n¼13)
.3671.96 14.0073.41 16.1773.04 15.6972.14
.0974.30 11.4472.99n 12.2572.26 13.1574.32
.0974.04n 9.7873.40n 9.6673.55 10.4674.50
n 68n 83 76
83n 77 81
5870.44 5.1770.82 4.6370.75# 4.7370.91#
Fig. 3. Proportion (%) of fetuses classiﬁed as small (SPA), adequate (APA) and large
(LPA) for gestational age in all groups at term pregnancy. *Signiﬁcant difference as
compared to ND; #Signiﬁcant difference as compared to D. po0.05—Chi
Square Test.
Table 3
Oxidative stress proﬁle in washed erythrocytes sampled from rats at term pregnancy.
ND (n¼13) NDOil (n¼12) NDPA (n¼12) D (n¼13) DOil (n¼12) DPA (n¼13)
SOD (UI/mg Hb) 11.4470.48 11.4570.95 11.3270.55 12.5071.16 11.5470.13 11.5670.14
Thiol groups (mM/g Hb) 3.6471.30 4.1770.74 4.3870.51 5.1172.17 4.3970.59 4.3070.52
GSH-Px (UI/mg Hb) 0.2670.10 0.2270.09 0.2670.06 0.2870.09 0.2270.08 0.2570.06
MDA (nM/g Hb) 166.54785.59 501.27172.7n 542.94795.06n 582.947219.32n 641.837152.58 501.187138.03
Values are expressed as mean7SD.
n Signiﬁcantly different from ND; po0.05–Test of Multiple Comparison of Tukey.
Table 4
Lipid proﬁle in blood sampled from rats at term pregnancy.
ND (n¼13) NDOil (n¼12) NDPA (n¼12) D (n¼13) DOil (n¼12) DPA (n¼13)
Cholesterol (mg/dL)a 128736 119731 109721 155743 113728# 128724
Triglycerides (mg/dL) 2467182 3297187 4817208 3987251 3037196 4527214
HDL (mg/dL) 45.9710.0 46.379.7 39.6710.0 44.9712.4 54.6711.3 50.7717.4
Non-esteriﬁed fatty acids (mEq NEFA/L)b 0.4370.16 0.6370.40 0.6570.40 1.4671.18n 0.4370.30# 0.4570.21
Values are expressed as mean7SD.
n Signiﬁcantly different from ND.
# Signiﬁcantly different from D.
a po0.05—Test of Multiple Comparison of Tukey.
b po0.05—Test of log Binomial Distribution.
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disturbances.
In treated non-diabetic rats, we found that neem oil and
azadirachtin increased resorption rates. According to Mukherjee
et al. (1999), treatment with the active fraction of neem seed and
leaf extracts causes a speciﬁc activation of T lymphocyte cells of
CD8þ subtype as well as phagocytic cells followed by elevation in
cytokines gamma-interferon and TNF. Therefore, the increase
in pro-inﬂammatory cytokines might have contributed to elevate
resorption rates in rats treated with neem in our study. Further-
more, the fact that the number of live fetuses was reduced in
non-diabetic animals treated with azadirachtin shows that this
treatment adversely affected embryo–fetal development as in
diabetic rats. Srivastava and Raizada (2007) veriﬁed that female
rats treated with a diet supplemented with azadirachtin (100, 500
and 1000 ppm) presented no alterations in the maternal repro-
ductive performance and in the post-natal development in two
generations. Afterward the different treatments did not protect
the embryos and fetuses from diabetes-induced damages.
Clinical studies have shown that fetuses from type 2 diabetes
women (Farquhar, 1959) are large for gestational age (LGA). In
contrast, the fetuses of mild diabetic rats are frequently small for
gestational age (SGA) at term pregnancy (Iessi et al., 2010; Kiss
et al., 2009, Aerts and Van Assche, 2006; Holemans et al., 2003),
rarely showing macrosomia before birth. This is explained by the
fact that fat depot accumulation takes place intra uterus in
humans, whereas in rats it occurs after birth (Herrera and
Amusquivar, 2000; Lo´pez-Soldado and Herrera, 2003). The ele-
vated rate of SGA fetuses observed among the rats treated with oil
and azadirachtin in this study suggests that some components of
the neem plant might have impaired fetal development.
Normal human pregnancy is a state of enhanced oxidative
stress owing to an increased metabolic activity in the placenta
mitochondria, which generates reactive oxygen species (ROS), as
well as a defect in antioxidant defenses (Lappas et al., 2011).
During diabetic pregnancy, there are increased levels of lipo-
peroxidation (Myatt and Cui, 2004), and an excess amount ofsuperoxide is produced in response to hyperglycemia (Noh and
Ha, 2011). In this study, exacerbated lipoperoxidation was evi-
denced by the increased MDA concentrations found in diabetic
animals. The non-diabetic dams treated with neem oil and azadir-
achtin also showed increased oxidative stress, suggesting that
besides impairing oxidant/antioxidant status in non-diabetic rats,
they did not have any protective effect on the diabetic animals. On
the other hand, beneﬁcial effects such as decreased lipoperoxides
and higher levels of superoxide dismutase, catalase and glu-
tathione oxidized (Gupta et al., 2004; Chandra et al., 2008) have
also been reported.
In all animal groups herein investigated, treatment with neem
oil and azadirachtin had no effect on the levels of triglycerides,
cholesterol and HDL. The only exception was the diabetic
group that showed decreased total cholesterol levels as observed
by Bisht and Sisodia (2010) in diabetic males treated with neem
seed ethanol extract. Our results show that NEFA levels were
reduced in the diabetic animals treated with neem oil
and azadirachtin. This might be explained by the high amount
of linoleic acid found in neem oil. Studies have shown that
conjugated linoleic acid (CLA) exerts antidiabetogenic, anticarci-
nogenic, and antiatherosclerotic effects (Belury and Vanden
Heuvel, 1997, 1999) on the immune system as well as on fatty
acid and lipid metabolism (Belury and Vanden Heuvel, 1997;
Eggert et al., 2002). Indeed, Belury and Vanden Heuvel (1999)
observed signiﬁcantly lower free fatty acid levels in diabetic
Zucker rats fed with semipuriﬁed diets containing 1.5% CLA than
in controls.5. Conclusion
Besides impairing reproductive performance in non-diabetic
pregnant rats, neem seed oil and its active principle (azadirachtin)
showed no anti-hyperglycemic or hypoglycemic effect, delayed
fetal growth, increased oxidative stress, but it showed reduced
NEFA levels. These results show that awareness about the
B. Dallaqua et al. / Journal of Ethnopharmacology 143 (2012) 805–811810indiscriminate use of natural products should be raised, especially
among pregnant women without due knowledge of their effects.Acknowledgments
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